Myomo Inc
AMEX:MYO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Myomo Inc
Other Long-Term Assets
Myomo Inc
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Myomo Inc
AMEX:MYO
|
Other Long-Term Assets
$596.4k
|
CAGR 3-Years
75%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Long-Term Assets
$4.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
23%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Other Long-Term Assets
$1.9B
|
CAGR 3-Years
31%
|
CAGR 5-Years
41%
|
CAGR 10-Years
19%
|
|
|
Stryker Corp
NYSE:SYK
|
Other Long-Term Assets
$3.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
12%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Other Long-Term Assets
$18.4B
|
CAGR 3-Years
42%
|
CAGR 5-Years
38%
|
CAGR 10-Years
22%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Long-Term Assets
$1.7B
|
CAGR 3-Years
11%
|
CAGR 5-Years
16%
|
CAGR 10-Years
26%
|
|
Myomo Inc
Glance View
Myomo, Inc. is a medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The company is headquartered in Boston, Massachusetts and currently employs 100 full-time employees. The company went IPO on 2017-06-12. The firm offers functional improvement for those with neuromuscular disorders and upper limb paralysis. The firm develops and markets the MyoPro product line. The MyoPro is a myoelectric-controlled upper limb brace (orthosis). The orthosis is a rigid brace used for the purpose of supporting a patient’s weak or paralyzed arm to enable and help improve functional activities of daily living (ADLs), in the home and community. The MyoPro can enable individuals to self-initiate and control movements of a partially paralyzed or weakened limb using their own muscle signals. The Company’s products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury and other neurological disorders. The company primarily provides devices directly to patients and bills their insurance companies.
See Also
What is Myomo Inc's Other Long-Term Assets?
Other Long-Term Assets
596.4k
USD
Based on the financial report for Dec 31, 2025, Myomo Inc's Other Long-Term Assets amounts to 596.4k USD.
What is Myomo Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 3Y
75%
Over the last year, the Other Long-Term Assets growth was 11%. The average annual Other Long-Term Assets growth rates for Myomo Inc have been 75% over the past three years .
